BCA
KURA icon

Berman Capital Advisors’s Kura Oncology KURA Stock Holding History

Berman Capital Advisors’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3K Buy
201
+44
+28% +$829 ﹤0.01% 1593
2021
Q2 		$3K Hold
157
– – ﹤0.01% 1498
2021
Q1 		$4K Hold
157
– – ﹤0.01% 1343
2020
Q4 		$5K Hold
157
– – ﹤0.01% 1152
2020
Q3 		$4K Hold
157
– – ﹤0.01% 1113
2020
Q2 		$2K Buy
+157
New +$2.27K ﹤0.01% 1284

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Berman Capital Advisors's KURA Position: Q3 2021 in Review

Berman Capital Advisors increased its Kura Oncology (KURA) stake by 28% in Q3 2021, buying an estimated $829 and bringing the position to 201 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Berman Capital Advisors first reported a position in KURA in Q2 2020 and has held it in 6 quarters since. The position peaked at $5K in Q4 2020. 152 funds tracked by Wall St. Rank hold KURA as of Q3 2021.

  • Berman Capital Advisors held 201 shares of Kura Oncology worth $3K as of Q3 2021.
  • Berman Capital Advisors bought 44 Kura Oncology shares in Q3 2021, an estimated $829.
  • Kura Oncology made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1593 holding.
  • Berman Capital Advisors first reported a position in Kura Oncology in Q2 2020 and has held it in 6 quarters since.
  • Berman Capital Advisors's Kura Oncology position peaked at $5K in Q4 2020.
  • 152 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.